• Mitoxantrone Allosterically Degrades ERα via DBD-LBD Interfa

  2026-07-14

  Wang et al. reveal that mitoxantrone, beyond its DNA topoisomerase II inhibition, targets a novel interface between the DNA-binding and ligand-binding domains of estrogen receptor alpha (ERα), leading to proteasomal degradation. This mechanism overcomes resistance in ER-positive breast cancer models and introduces a new paradigm for nuclear receptor inhibition.

• Cyclosporin A: Optimizing T-Cell Suppression & Mitochondrial

  2026-07-14

  Cyclosporin A's unique cyclic structure enables precise immunosuppression and mitochondrial pore inhibition in both cell-based and in vivo models. This article decodes advanced workflows, experimental pitfalls, and new insights from structural research—empowering you to maximize reproducibility and interpretability in immunology and mitochondrial studies.

• Tobramycin: Aminoglycoside Antibiotic for Advanced Research

  2026-07-13

  Tobramycin from APExBIO stands out as a water-soluble aminoglycoside antibiotic, enabling high-precision workflows to investigate Gram-negative bacterial resistance and protein synthesis inhibition. This article delivers actionable protocol enhancements, troubleshooting insights, and comparative context to accelerate robust microbiology results.

• Oligo (dT) 25 Beads: Precision Eukaryotic mRNA Isolation

  2026-07-13

  Oligo (dT) 25 Beads transform eukaryotic mRNA isolation with rapid, high-yield capture, streamlining workflows for transcriptomics and multiomics. Their superparamagnetic design ensures reproducibility and purity, making them essential for advanced gene expression studies and downstream applications.

• Fenofibrate as a PPARα Agonist: Applied Workflows & Key Insi

  2026-07-12

  Fenofibrate, a potent PPARα agonist, is revolutionizing lipid metabolism and cancer biology research through its robust activation of the PPARα-YAP axis. This article delivers hands-on experimental workflows, advanced troubleshooting, and protocol refinements for maximizing data reliability using APExBIO's Fenofibrate in both adult and aging models.

• High-Fidelity PCR for Neurodegeneration: HyperFusion™ in Act

  2026-07-10

  Explore how HyperFusion high-fidelity DNA polymerase enables ultra-precise PCR amplification for neurodegeneration research. This article delivers new scientific insights and practical protocols, uniquely bridging molecular fidelity with emerging disease models.

• 5-Azacytidine Triggers ATR-Driven DNA Damage and Apoptosis i

  2026-07-09

  This study demonstrates that 5-Azacytidine induces ATR-mediated DNA double-strand break responses and apoptosis in multiple myeloma cells, including drug-resistant lines. The findings establish a mechanistic basis for combining 5-AzaC with doxorubicin or bortezomib, supporting its translational value in difficult-to-treat hematologic malignancies.

• CD28-ARS2 Axis Drives PKM Splicing and CD8+ T Cell Flexibili

  2026-07-09

  This study uncovers how CD28-induced ARS2 upregulation orchestrates alternative splicing of pyruvate kinase (PKM) in activated CD8+ T cells. The findings demonstrate a previously unrecognized mechanism linking co-stimulatory signaling to metabolic reprogramming, critical for effective antitumor immunity.

• Allosteric Biosensor Enables Live-Cell Tracking of Native Pr

  2026-07-08

  This study introduces an allosteric genetically encoded biosensor system for real-time, in situ visualization of endogenous protein dynamics within living cells. The platform allows high-precision, artifact-free tracking of protein localization and abundance, addressing key limitations of current protein imaging approaches and expanding opportunities for mechanistic studies and drug screening.

• Pertussis Toxin in Precision Immune Modulation Research

  2026-07-08

  Explore how Pertussis toxin, a classic AB5-type protein exotoxin, enables precision immune response modulation in cutting-edge immunology research. This article reveals advanced assay strategies, recent mechanistic insights, and practical workflow implications for scientists.

• Advancing Translational Imaging: D-Luciferin Potassium Salt

  2026-07-07

  Explore the mechanistic underpinnings and strategic potential of D-Luciferin (potassium salt) in translational research. This thought-leadership article bridges in vivo bioluminescence imaging advances with real-world protocol guidance, featuring recent discoveries in plant defense regulation and workflow innovations for tumor cell tracking and reporter assays.

• RepSox (ALK5 Inhibitor): Redefining Stem Cell Reprogramming

  2026-07-07

  Explore how RepSox, a potent ALK5 inhibitor, drives breakthroughs in induced pluripotent stem cell reprogramming and differentiation. This article delivers fresh insight into RepSox’s mechanistic advantages and practical use in advanced stem cell research.

• Schisandra Decoction Modulates PI3K/AKT/mTOR in Parkinson’s

  2026-07-06

  This study demonstrates that Schisandra Decoction (Sch D) alleviates motor deficits and reduces α-synuclein aggregation in a Parkinson’s disease mouse model by modulating the PI3K/AKT/mTOR pathway. The work provides new mechanistic insights into traditional Chinese medicine’s neuroprotective potential and highlights relevant molecular endpoints for future gene expression analysis.

• Optimizing Cell Membrane Staining with DiD (DiDC 18 (5)) Pro

  2026-07-06

  DiD (DiDC 18 (5)) enables precise, high-contrast plasma membrane labeling for advanced cell tracking and immunofluorescence workflows—even in tissues with high autofluorescence or inflammation. Its superior spectral properties and robust compatibility make it a cornerstone for neuronal tracing and cell migration assays, as highlighted by recent breakthroughs in inflammatory disease models.

• Intermedin, NAMPT/PARP1, and Vascular Aging: Mechanistic Ins

  2026-07-05

  Ji et al. (2025) reveal that intermedin (IMD) prevents the DNA damage-driven senescent transition of vascular smooth muscle cells (VSMCs) in mouse aorta by activating NAMPT and PARP1. This mechanistic advance provides a new perspective on targeting NAD metabolism to counteract vascular aging processes.

444 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page